Aims and Scope of Nature Reviews Drug Discovery
Nature Reviews Drug Discovery is a peer-reviewed review journal covering drug discovery and development. According to the Journal Citation Reports, the journal has a 2019 impact factor of 64.797. Reviews are commissioned to specialists and supplemented with glossary explanations for non-specialist readers and illustrated with figures drawn by Nature's in-house art editors. Besides reviews, the journal publishes analysis articles based on existing datasets (e.g. metaanalysis), progress articles that focus on outstanding issues, and perspective articles—typically opinions or historical pieces. Less
Key Metrics
CiteScore 

65.9
Eigenfactor 

0.01 - 0.05
Impact Factor 

>= 25
Scite Index 

0.96 5-Year SI

SJR 

Q1Pharmacology

SNIP 

14.86
Recommended pre-submission checks
Powered by 

Topics Covered on Nature Reviews Drug Discovery
Nature Reviews Drug Discovery Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | NATURE PORTFOLIO |
| Language | English |
| Frequency | Monthly |
| General Details |
View less
Planning to publish in Nature Reviews Drug Discovery ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Nature Reviews Drug Discovery
Halda secures biggest induced-proximity deal yet, with J&J's US$3 billion buy out.
- 1 Jan 2026
- Nature reviews. Drug discovery
Stimulating medicines repurposing in the EU: a pilot project.
- 1 Jan 2026
- Nature reviews. Drug discovery
Trends in gene therapy delivery technologies.
- 1 Jan 2026
- Nature reviews. Drug discovery
Microsystem technologies for accelerating the discovery and translation of immunotherapies.
- 1 Jan 2026
- Nature reviews. Drug discovery
First-in-class APRIL inhibitor secures approval for rare kidney disease.
- 1 Jan 2026
- Nature reviews. Drug discovery
Synthetic lethality in cancer drug discovery: challenges and opportunities.
- 1 Jan 2026
- Nature reviews. Drug discovery
Halda secures biggest induced-proximity deal yet, with J&J's US$3 billion buy out.
- 1 Jan 2026
- Nature reviews. Drug discovery
Stimulating medicines repurposing in the EU: a pilot project.
- 1 Jan 2026
- Nature reviews. Drug discovery
Trends in gene therapy delivery technologies.
- 1 Jan 2026
- Nature reviews. Drug discovery
Microsystem technologies for accelerating the discovery and translation of immunotherapies.
- 1 Jan 2026
- Nature reviews. Drug discovery
First-in-class APRIL inhibitor secures approval for rare kidney disease.
- 1 Jan 2026
- Nature reviews. Drug discovery
Synthetic lethality in cancer drug discovery: challenges and opportunities.
- 1 Jan 2026
- Nature reviews. Drug discovery